{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:40:20Z","timestamp":1759974020924,"version":"build-2065373602"},"reference-count":196,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.medmal.2009.02.018","type":"journal-article","created":{"date-parts":[[2009,5,10]],"date-time":"2009-05-10T04:44:55Z","timestamp":1241930695000},"page":"499-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["M\u00e9ningites pr\u00e9sum\u00e9es bact\u00e9riennes communautaires de l\u2019adulte\u00a0: antibioth\u00e9rapie initiale"],"prefix":"10.1016","volume":"39","author":[{"given":"P.","family":"Chavanet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2009.02.018_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0736-4679(01)00407-3","article-title":"Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center","volume":"21","author":"Miner","year":"2001","journal-title":"J Emerg Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/qjmed\/hci047","article-title":"Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis","volume":"98","author":"Proulx","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.medmal.2009.02.018_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s15010-007-6202-0","article-title":"Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome","volume":"35","author":"Lepur","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.018_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00004","article-title":"Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing","volume":"129","author":"Aronin","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-4453(99)90095-6","article-title":"Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party","volume":"39","author":"Begg","year":"1999","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2009.02.018_bib6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jac\/49.4.661","article-title":"Antibiotic guidelines and antibiotic use in adult bacterial meningitis in the Netherlands","volume":"49","author":"Van de Beek","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(07)70050-6","article-title":"Emergency diagnosis and treatment of adult meningitis","volume":"7","author":"Fitch","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/jnnp.2007.139725","article-title":"Community-acquired bacterial meningitis in adults","volume":"8","author":"Schut","year":"2008","journal-title":"Pract Neurol"},{"key":"10.1016\/j.medmal.2009.02.018_bib10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1542\/peds.102.5.1087","article-title":"Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use","volume":"102","author":"Arditi","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2009.02.018_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00006454-200210000-00004","article-title":"Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study","volume":"21","author":"Kellner","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2009.02.018_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s15010-001-1092-z","article-title":"Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains","volume":"29","author":"Chang","year":"2001","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.018_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7883\/yoken.JJID.2007.397","article-title":"Adult Pseudomonas aeruginosa meningitis: high incidence of underlying medical and\/or postneurosurgical conditions and high mortality rate","volume":"60","author":"Huang","year":"2007","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/314034","article-title":"Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus","volume":"31","author":"Lu","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0303-8467(01)00128-7","article-title":"Streptococcal meningitis in adults: therapeutic outcomes and prognostic factors","volume":"103","author":"Lu","year":"2001","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.medmal.2009.02.018_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1054\/jocn.2001.1032","article-title":"Klebsiella meningitis in adults: clinical features, prognostic factors and therapeutic outcomes","volume":"9","author":"Lu","year":"2002","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.medmal.2009.02.018_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0195-6701(98)90021-4","article-title":"The prognostic factors of adult gram-negative bacillary meningitis","volume":"40","author":"Lu","year":"1998","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.medmal.2009.02.018_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/00006454-200211000-00013","article-title":"Acute bacterial meningitis in children admitted to a rural Kenyan hospital: increasing antibiotic resistance and outcome","volume":"21","author":"Mwangi","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2009.02.018_bib19","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1001\/archinte.1993.00410160066005","article-title":"Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases","volume":"153","author":"Jensen","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199001183220301","article-title":"A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children","volume":"322","author":"Schaad","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(83)92696-X","article-title":"Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children","volume":"1","author":"del Rio","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2009.02.018_bib22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(89)92685-8","article-title":"Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group","volume":"1","author":"Peltola","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2009.02.018_bib23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1542\/peds.108.5.1169","article-title":"Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment","volume":"108","author":"Kanegaye","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2009.02.018_bib24","first-page":"1227","article-title":"Bacterial concentration in the cerebrospinal fluid in childhood meningitis","volume":"28","author":"Mariani-Kurkdjian","year":"1999","journal-title":"Presse Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/515003","article-title":"Antibiotic pharmacodynamics in cerebrospinal fluid","volume":"27","author":"Lutsar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.idc.2004.04.005","article-title":"Antimicrobial agents in the treatment of bacterial meningitis","volume":"18","author":"Sinner","year":"2004","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medmal.2009.02.018_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0891-5520(05)70096-9","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in meningitis","volume":"13","author":"Andes","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medmal.2009.02.018_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-199835030-00005","article-title":"Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections","volume":"35","author":"Nau","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.medmal.2009.02.018_bib29","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1128\/AAC.41.11.2414","article-title":"Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis","volume":"41","author":"Lutsar","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib30","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/AAC.42.10.2650","article-title":"Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis","volume":"42","author":"Lutsar","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.43.4.876","article-title":"Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis","volume":"43","author":"Ahmed","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib32","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.addr.2004.07.011","article-title":"Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics","volume":"56","author":"Shen","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.medmal.2009.02.018_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-510X(94)90052-3","article-title":"Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges","volume":"122","author":"Nau","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.medmal.2009.02.018_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.6.4.437","article-title":"Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives","volume":"6","author":"Dacey","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2007.02.002","article-title":"Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role","volume":"30","author":"Roberts","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2009.02.018_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1128\/AAC.41.5.987","article-title":"Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients","volume":"41","author":"Nau","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib37","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/AAC.37.7.1518","article-title":"Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges","volume":"37","author":"Nau","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib38","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/AAC.47.10.3155-3160.2003","article-title":"Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib39","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0924-8579(03)00041-4","article-title":"Does dexamethasone affect ceftriaxone [corrected] penetration into cerebrospinal fluid in adult bacterial meningitis","volume":"21","author":"Buke","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2009.02.018_bib40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1592\/phco.23.3.310.32108","article-title":"Disposition of cefepime in the central nervous system of patients with external ventricular drains","volume":"23","author":"Rhoney","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medmal.2009.02.018_bib41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diagmicrobio.2007.03.015","article-title":"Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae","volume":"58","author":"Lodise","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.diagmicrobio.2005.09.007","article-title":"Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies","volume":"54","author":"Lodise","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/45.1.63","article-title":"Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro","volume":"45","author":"Gerber","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/AAC.40.3.763","article-title":"Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies","volume":"40","author":"Nau","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib45","first-page":"201","article-title":"Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection","volume":"9","author":"Parish","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.medmal.2009.02.018_bib46","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1128\/AAC.00590-07","article-title":"Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections","volume":"51","author":"Talbot","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/jac\/dkm492","article-title":"In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin","volume":"61","author":"Pillar","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/AAC.29.4.670","article-title":"Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections","volume":"29","author":"Jacobs","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib49","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jac\/16.6.751","article-title":"Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis","volume":"16","author":"Modai","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/34.1.175","article-title":"Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges","volume":"34","author":"Dagan","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/AAC.39.5.1140","article-title":"Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group","volume":"39","author":"Klugman","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00148581-200608020-00005","article-title":"Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis: a report from the OPTAMA program","volume":"8","author":"Ellis","year":"2006","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.medmal.2009.02.018_bib53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1211\/0022357001774912","article-title":"Comparative cerebrospinal fluid diffusion of imipenem and meropenem in rats","volume":"52","author":"Dupuis","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.medmal.2009.02.018_bib54","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-008-0492-8","article-title":"Experimental study of meropenem in the therapy of cephalosporin-susceptible and -resistant pneumococcal meningitis","author":"Force","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s100960050421","article-title":"Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain","volume":"18","author":"Gerber","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib56","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/00007611-200295110-00013","article-title":"Pneumococcal susceptibility to meropenem in a mid-south children's hospital","volume":"95","author":"Buckingham","year":"2002","journal-title":"South Med J"},{"key":"10.1016\/j.medmal.2009.02.018_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3346\/jkms.2004.19.1.21","article-title":"Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis","volume":"19","author":"Kim","year":"2004","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.medmal.2009.02.018_bib58","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10096-003-1016-1","article-title":"Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis","volume":"22","author":"Cottagnoud","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra993637","article-title":"Cephalosporin allergy","volume":"345","author":"Kelkar","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib60","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jac\/dkn004","article-title":"Activity of doripenem and comparator beta-lactams against US clinical isolates of Streptococcus pneumoniae with defined mutations in the penicillin-binding domains of pbp1a, pbp2b and pbp2x","volume":"61","author":"Davies","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14656566.9.1.23","article-title":"Carbapenems: a potent class of antibiotics","volume":"9","author":"Nicolau","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.medmal.2009.02.018_bib62","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jac\/dki019","article-title":"In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339\u00a0strains","volume":"55","author":"Decousser","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib63","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/AAC.47.6.1943-1947.2003","article-title":"Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis","volume":"47","author":"Cottagnoud","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib64","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1128\/AAC.44.5.1356-1358.2000","article-title":"Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit","volume":"44","author":"Albanese","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/510390","article-title":"Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study","volume":"44","author":"Ricard","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib66","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/AAC.35.12.2467","article-title":"Evaluation of vancomycin for therapy of adult pneumococcal meningitis","volume":"35","author":"Viladrich","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00000441-200508000-00003","article-title":"Vancomycin-tolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001","volume":"330","author":"Gillis","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.medmal.2009.02.018_bib68","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1086\/318697","article-title":"Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin","volume":"32","author":"Henriques Normark","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib69","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/21202","article-title":"Emergence of vancomycin tolerance in Streptococcus pneumoniae","volume":"399","author":"Novak","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.medmal.2009.02.018_bib70","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/424467","article-title":"Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact","volume":"190","author":"Rodriguez","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/315216","article-title":"Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis","volume":"181","author":"McCullers","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib72","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1128\/JCM.00558-06","article-title":"Vancomycin-tolerant Streptococcus pneumoniae in Korea","volume":"44","author":"Sung","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.018_bib73","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/AAC.47.1.211-215.2003","article-title":"Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci","volume":"47","author":"Rodriguez-Cerrato","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib74","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1592\/phco.23.15.1531.31964","article-title":"Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model","volume":"23","author":"Cha","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medmal.2009.02.018_bib75","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1128\/AAC.47.6.1984-1987.2003","article-title":"Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model","volume":"47","author":"Cha","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijantimicag.2005.08.011","article-title":"Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis","volume":"26","author":"Sipahi","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2009.02.018_bib77","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkh496","article-title":"Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis","volume":"55","author":"Fernandez","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jac\/20.1.141","article-title":"Poor penetration of teicoplanin into cerebrospinal fluid in patients with bacterial meningitis","volume":"20","author":"Stahl","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib79","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.48.10.3928-3933.2004","article-title":"Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis","volume":"48","author":"Cottagnoud","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib80","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jac\/dkl007","article-title":"Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis","volume":"57","author":"Gerber","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib81","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.01014-06","article-title":"Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis","volume":"51","author":"Grandgirard","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib82","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/AAC.01000-06","article-title":"Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall","volume":"51","author":"Stucki","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib83","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jac\/dkm078","article-title":"In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives","volume":"59","author":"Cafini","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib84","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/AAC.47.6.1907-1911.2003","article-title":"Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis","volume":"47","author":"Cabellos","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00006454-200201000-00004","article-title":"Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin","volume":"21","author":"Saez-Llorens","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2009.02.018_bib86","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.41.6.1298","article-title":"Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin","volume":"41","author":"Cutler","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib87","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.39.3.593","article-title":"Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits","volume":"39","author":"Nau","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib88","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1128\/AAC.39.6.1243","article-title":"Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis","volume":"39","author":"Paris","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","article-title":"Immunomodulatory effects of quinolones","volume":"3","author":"Dalhoff","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib90","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jac\/39.6.781","article-title":"Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis","volume":"39","author":"Nau","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib91","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00365549950163806","article-title":"Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone","volume":"31","author":"Stuertz","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib92","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/AAC.42.6.1397","article-title":"Moxifloxacin in the therapy of experimental pneumococcal meningitis","volume":"42","author":"Schmidt","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib93","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/AAC.42.7.1706","article-title":"Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits","volume":"42","author":"Ostergaard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jac\/46.2.249","article-title":"Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model","volume":"46","author":"Gerber","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib95","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1128\/AAC.46.5.1607-1609.2002","article-title":"Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis","volume":"46","author":"Cottagnoud","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib96","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1086\/323406","article-title":"Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis","volume":"33","author":"Scotton","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib97","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1128\/AAC.47.10.3104-3108.2003","article-title":"Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy","volume":"47","author":"Pea","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 3","key":"10.1016\/j.medmal.2009.02.018_bib98","article-title":"Moxifloxacin (MOX) levels in cerebrospinal fluid (CSF)","volume":"17","author":"Pagoulatou","year":"2005","journal-title":"J Chemother"},{"issue":"Supp. 1","key":"10.1016\/j.medmal.2009.02.018_bib99","first-page":"72","article-title":"Pharmakokinetische undersuchung von moxifloxacin in liquor und seum von patienten mit blut-liquor-schrankenfunktionsstoriung versus kontrolgruppe","volume":"35","author":"Verheggen","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.018_bib100","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jac\/dkn110","article-title":"Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect","volume":"61","author":"Kanellakopoulou","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib101","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/47.5.611","article-title":"Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model","volume":"47","author":"Destache","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib102","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/AAC.45.11.3092-3097.2001","article-title":"Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis","volume":"45","author":"Rodriguez-Cerrato","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib103","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jac\/dkn001","article-title":"Moxifloxacin versus ampicillin+gentamicin in the therapy of experimental Listeria monocytogenes meningitis","volume":"61","author":"Sipahi","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib104","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.38.8.1849","article-title":"Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400\u00a0milligrams of ofloxacin","volume":"38","author":"Nau","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib105","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1128\/AAC.47.8.2487-2491.2003","article-title":"Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro","volume":"47","author":"Kuhn","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib106","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jac\/dkh082","article-title":"Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci","volume":"53","author":"Flatz","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.medmal.2009.02.018_bib107","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/314060","article-title":"Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis","volume":"31","author":"McCracken","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2009.02.018_bib108","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1089\/107662903322541900","article-title":"Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis","volume":"9","author":"Domenech","year":"2003","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.medmal.2009.02.018_bib109","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/INF.0b013e3180cbd2c7","article-title":"Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia","volume":"26","author":"Bradley","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2009.02.018_bib110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijantimicag.2006.09.025","article-title":"Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study","volume":"29","author":"Ross","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2009.02.018_bib111","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/AAC.00515-06","article-title":"Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains","volume":"51","author":"Beer","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib112","doi-asserted-by":"crossref","unstructured":"Malacarne P, Viaggi B, A DIP, Danesi R, Del Tacca M. Linezolid cerebrospinal fluid concentration in central nervous system infection. J Chemother 2007;19:90\u20133.","DOI":"10.1179\/joc.2007.19.1.90"},{"key":"10.1016\/j.medmal.2009.02.018_bib113","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/AAC.46.3.936-937.2002","article-title":"Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections","volume":"46","author":"Villani","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib114","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/JCM.42.2.929-932.2004","article-title":"Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid","volume":"42","author":"Krueger","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.018_bib115","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.00051-06","article-title":"Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients","volume":"50","author":"Myrianthefs","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib116","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/46.6.981","article-title":"Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model","volume":"46","author":"Cottagnoud","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib117","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/AAC.47.2.548-553.2003","article-title":"Population pharmacokinetics of linezolid in patients treated in a compassionate-use program","volume":"47","author":"Meagher","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib118","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1097\/01.inf.0000086954.43010.63","article-title":"Linezolid pharmacokinetics in pediatric patients: an overview","volume":"22","author":"Jungbluth","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2009.02.018_bib119","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/00006454-200012000-00012","article-title":"Single dose pharmacokinetics of linezolid in infants and children","volume":"19","author":"Kearns","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2009.02.018_bib120","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1128\/AAC.49.12.5013-5017.2005","article-title":"Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis","volume":"49","author":"Beringer","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib121","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.01194-06","article-title":"Pharmacokinetic\/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model","volume":"51","author":"Boak","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib122","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1128\/AAC.46.12.3706-3711.2002","article-title":"In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model","volume":"46","author":"Jacqueline","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib123","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2165\/00003088-200342150-00007","article-title":"Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme","volume":"42","author":"Rayner","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.medmal.2009.02.018_bib124","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archinte.1951.03810100073006","article-title":"Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin","volume":"88","author":"Lepper","year":"1951","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib125","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.47.6.1902-1906.2003","article-title":"In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms","volume":"47","author":"Sweeney","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib126","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1345\/aph.1H307","article-title":"Linezolid for the treatment of patients with central nervous system infection","volume":"41","author":"Ntziora","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.medmal.2009.02.018_bib127","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1469-0691.2006.01352.x","article-title":"Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains","volume":"12","author":"Faella","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2009.02.018_bib128","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00134-007-0557-7","article-title":"Linezolid as rescue therapy for pneumococcal meningitis","volume":"33","author":"Ramirez","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib129","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/00365540110080467","article-title":"Linezolid for the treatment of central nervous system infections in neurosurgical patients","volume":"34","author":"Viale","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s15010-007-6211-z","article-title":"Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid","volume":"35","author":"Kessler","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.018_bib131","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jinf.2004.04.002","article-title":"Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin","volume":"50","author":"Amod","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2009.02.018_bib132","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10096-006-0097-z","article-title":"Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment","volume":"25","author":"Kruse","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib133","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/00365540410019345","article-title":"Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid","volume":"36","author":"Pistella","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib134","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1345\/aph.1H029","article-title":"Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis","volume":"40","author":"Boak","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.medmal.2009.02.018_bib135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/jinf.2002.0979","article-title":"Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid","volume":"45","author":"Gill","year":"2002","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2009.02.018_bib136","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1368-5031.2006.00706.x","article-title":"Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis","volume":"60","author":"Tsai","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.medmal.2009.02.018_bib137","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/00006454-200208000-00025","article-title":"Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis","volume":"21","author":"Graham","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2009.02.018_bib138","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0732-8893(02)00523-0","article-title":"Treatment of central nervous system infection by vancomycin-resistant Enterococcus faecium","volume":"45","author":"Kanchanapoom","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib139","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1590\/S1413-86702007000200027","article-title":"Successful treatment of vancomycin-resistant Enterococcus ventriculitis in a child","volume":"11","author":"da Silva","year":"2007","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib140","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/PL00011286","article-title":"Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid","volume":"20","author":"Hachem","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib141","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/003655401750174048","article-title":"Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review","volume":"33","author":"Shaikh","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib142","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1097\/00003246-200112000-00023","article-title":"Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid: case report and review of the literature","volume":"29","author":"Steinmetz","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib143","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ijantimicag.2006.11.025","article-title":"Treatment of vancomycin-resistant Enterococcus faecium ventriculitis in a neonate","volume":"29","author":"Kumar","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2009.02.018_bib144","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/321896","article-title":"Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature","volume":"33","author":"Zeana","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib145","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.jinf.2005.06.012","article-title":"A case of rhombencephalitis caused by Listeria monocytogenes successfully treated with linezolid","volume":"52","author":"Morosi","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2009.02.018_bib146","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1086\/431770","article-title":"Treatment of brain abscess due to Listeria monocytogenes","volume":"41","author":"Lorber","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib147","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1179\/joc.2006.18.3.331","article-title":"Listeria monocytogenes meningitis and multiple brain abscesses in an immunocompetent host. Favorable response to combination linezolid-meropenem treatment","volume":"18","author":"Manfredi","year":"2006","journal-title":"J Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib148","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000238009","article-title":"Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis","volume":"27","author":"Sicilia","year":"1981","journal-title":"Chemotherapy"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2009.02.018_bib149","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000222087","article-title":"Fosfomycin in pneumococcal meningitis","volume":"23","author":"Sicilia","year":"1977","journal-title":"Chemotherapy"},{"issue":"Suppl 1","key":"10.1016\/j.medmal.2009.02.018_bib150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000222045","article-title":"A study of the levels of fosfomycin in the cerebrospinal fluid in adult meningitis","volume":"23","author":"Drobnic","year":"1977","journal-title":"Chemotherapy"},{"key":"10.1016\/j.medmal.2009.02.018_bib151","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/AAC.39.8.1736","article-title":"In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae","volume":"39","author":"Chavanet","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib152","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01968058","article-title":"Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits","volume":"9","author":"Chavanet","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib153","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/AAC.40.9.2062","article-title":"In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae","volume":"40","author":"Chavanet","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib154","first-page":"2135","article-title":"Fosfomycin-cefotaxime combination in severe staphylococcal infections in newborn infants","volume":"14","author":"Gouyon","year":"1985","journal-title":"Presse Med"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2009.02.018_bib155","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1007\/BF01644224","article-title":"Bactericidal activity of cefotaxime and fosfomycin in cerebrospinal fluid during the treatment of rabbit meningitis experimentally induced by methicillin-resistant Staphylococcus aureus","volume":"13","author":"Kazmierczak","year":"1985","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.018_bib156","first-page":"2161","article-title":"Treatment with a cefotaxime-fosfomycin combination of staphylococcal or enterobacterial meningitis in adults","volume":"16","author":"Portier","year":"1987","journal-title":"Presse Med"},{"issue":"Suppl. B","key":"10.1016\/j.medmal.2009.02.018_bib157","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jac\/14.suppl_B.277","article-title":"Treatment of severe staphylococcal infections with cefotaxime and fosfomycin in combination","volume":"14","author":"Portier","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib158","first-page":"556","article-title":"Cerebrospinal fluid diffusion kinetics of cefotaxime and fosfomycin in Staphylococcus aureus meningitis with otorrhea","volume":"32","author":"Tremeaux","year":"1984","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.medmal.2009.02.018_bib159","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jac\/36.6.997","article-title":"Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis","volume":"36","author":"Nau","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib160","first-page":"525","article-title":"Treatment of ventriculitis caused by Staphylococcus epidermidis on equipment with the combination of fosfomycin and an aminoglycoside. Course of ventricular levels of fosfomycin","volume":"31","author":"Boulard","year":"1983","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.medmal.2009.02.018_bib161","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/jac\/dkh158","article-title":"Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis","volume":"53","author":"Pfausler","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib162","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/dkl047","article-title":"Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae","volume":"57","author":"Ribes","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib163","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00701-002-1001-y","article-title":"Empirical treatment of adult postsurgical nosocomial meningitis","volume":"144","author":"De Bels","year":"2002","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.medmal.2009.02.018_bib164","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/AAC.41.1.49","article-title":"Once-daily gentamicin therapy for experimental Escherichia coli meningitis","volume":"41","author":"Ahmed","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/AAC.47.1.144-147.2003","article-title":"Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin","volume":"47","author":"Cottagnoud","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib166","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/AAC.46.1.188-190.2002","article-title":"Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model","volume":"46","author":"Cottagnoud","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib167","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/AAC.39.9.2158","article-title":"Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis","volume":"39","author":"Cabellos","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib168","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jac\/dki323","article-title":"Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916","volume":"56","author":"Ribes","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib169","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2807\/esm.11.07.00635-en","article-title":"Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005","volume":"11","author":"Rouaud","year":"2006","journal-title":"Euro Surveill"},{"key":"10.1016\/j.medmal.2009.02.018_bib170","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1086\/377739","article-title":"Neisseria meningitidis strains isolated from invasive infections in France (1999\u20132002): phenotypes and antibiotic susceptibility patterns","volume":"37","author":"Antignac","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib171","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/INF.0b013e3180616715","article-title":"Nontypeable Haemophilus influenzae meningitis in children: phenotypic and genotypic characterization of isolates","volume":"26","author":"Cardines","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2009.02.018_bib172","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/AAC.00335-07","article-title":"First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates","volume":"51","author":"Cerquetti","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib173","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/CMR.00040-06","article-title":"Antimicrobial resistance in Haemophilus influenzae","volume":"20","author":"Tristram","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medmal.2009.02.018_bib174","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jac\/dkl039","article-title":"Combination of altered PBPs and expression of cloned extended-spectrum beta-lactamases confers cefotaxime resistance in Haemophilus influenzae","volume":"57","author":"Bozdogan","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib175","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/jac\/dkm311","article-title":"Effect of cloned inhibitor-resistant TEM beta-lactamases on the susceptibility of Haemophilus influenzae to amoxicillin\/clavulanate","volume":"60","author":"Tristram","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib176","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jac\/dkm523","article-title":"Characterization of extended-spectrum beta-lactamase-producing isolates of Haemophilus parainfluenzae","volume":"61","author":"Tristram","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib177","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2807\/esm.11.06.00629-en","article-title":"Surveillance of human listeriosis in France, 2001\u20132003","volume":"11","author":"Goulet","year":"2006","journal-title":"Euro Surveill"},{"key":"10.1016\/j.medmal.2009.02.018_bib178","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/508462","article-title":"Community-acquired Listeria monocytogenes meningitis in adults","volume":"43","author":"Brouwer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib179","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0732-8893(00)00208-X","article-title":"In vitro activities of 22\u00a0antimicrobial agents against Listeria monocytogenes strains isolated in Barcelona, Spain. The Collaborative Study Group of Listeriosis of Barcelona","volume":"38","author":"Marco","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/JCM.41.1.483-485.2003","article-title":"Antimicrobial activities against 84\u00a0Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955\u20131997)","volume":"41","author":"Safdar","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.018_bib181","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/CMR.10.2.345","article-title":"Management of listeriosis","volume":"10","author":"Hof","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medmal.2009.02.018_bib182","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0732-8893(94)90014-0","article-title":"Assessment of the bactericidal activity of sparfloxacin, ofloxacin, levofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes","volume":"20","author":"Cherubin","year":"1994","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib183","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656566.5.8.1727","article-title":"An update on the medical management of listeriosis","volume":"5","author":"Hof","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.medmal.2009.02.018_bib184","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diagmicrobio.2006.11.010","article-title":"Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis","volume":"58","author":"Viale","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib185","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jac\/44.4.565","article-title":"Intracerebral activity of antibiotics against Listeria monocytogenes during experimental rhombencephalitis","volume":"44","author":"Blanot","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl A","key":"10.1016\/j.medmal.2009.02.018_bib186","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/36.suppl_A.73","article-title":"Efficacy of meropenem in experimental meningitis","volume":"36","author":"Nairn","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.018_bib187","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib188","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae","volume":"279","author":"Guillemot","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2009.02.018_bib189","first-page":"1129","article-title":"Risk factors for antibiotic resistance in Streptococcus pneumoniae","volume":"97","author":"Klugman","year":"2007","journal-title":"S Afr Med J"},{"key":"10.1016\/j.medmal.2009.02.018_bib190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1469-0691.2003.00520.x","article-title":"Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties","volume":"9","author":"Maugein","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2009.02.018_bib191","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/aje\/kwj021","article-title":"Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations","volume":"163","author":"Samore","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.medmal.2009.02.018_bib192","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1542\/peds.108.4.856","article-title":"High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission","volume":"108","author":"Samore","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2009.02.018_bib193","first-page":"1133","article-title":"Clinical significance of antimicrobial resistance in Streptococcus pneumoniae","volume":"97","author":"Jacobs","year":"2007","journal-title":"S Afr Med J"},{"key":"10.1016\/j.medmal.2009.02.018_bib194","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/CCM.0b013e318170ab08","article-title":"Caspases inhibition decreases neurological sequelae in meningitis","volume":"36","author":"Irazuzta","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medmal.2009.02.018_bib195","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1086\/587942","article-title":"Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis","volume":"197","author":"Grandgirard","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.018_bib196","doi-asserted-by":"crossref","unstructured":"17e Conf\u00e9rence de consensus en th\u00e9rapeutique anti-infectieuse de la Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise (SPILF). Prise en charge des m\u00e9ningites bact\u00e9riennes aigu\u00ebs communautaires (\u00e0 l\u2019exclusion du nouveau-n\u00e9). Texte court. Medmal 2009;39(3);175\u201386.","DOI":"10.1016\/j.medmal.2008.10.006"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X09000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X09000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:09:15Z","timestamp":1759972155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X09000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":196,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0399077X09000791"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2009.02.018","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9ningites pr\u00e9sum\u00e9es bact\u00e9riennes communautaires de l\u2019adulte\u00a0: antibioth\u00e9rapie initiale","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2009.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}